Under the effect of PD-1 blockade, patients with non-small-cell lung cancer (NSCLC) with high microbial diversity showed a higher abundance of peripheral-specific memory CD8+ T-cell and NK cell subsets [224]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.